Pharmaceuticals Anonymous

Sunday, May 29, 2011

Another Doctor on Big Pharma’s Payroll



When Dr. Victor Tapson, a Duke University researcher, wrote the Food and Drug Administration urging that the agency delay the approval of a generic blood thinner, it was a recommendation that carried some clout. Tapson, after all, was writing on behalf of the American College of Chest Physicians. But now it seems Tapson has some explaining to do. A Senate Finance Committee report released last week found that Tapson was on the payroll of a pharmaceutical company that was trying to protect its profits by blocking the release of a generic rival. POGO Investigator Paul Thacker explains how Tapson was part of a major lobbying push by drugmaker Sanofi-Aventis. Link